A detailed history of Shell Asset Management CO transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Shell Asset Management CO holds 16,800 shares of BHC stock, worth $122,472. This represents 0.01% of its overall portfolio holdings.

Number of Shares
16,800
Previous 17,400 3.45%
Holding current value
$122,472
Previous $140,000 27.14%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$7.77 - $10.61 $4,662 - $6,366
-600 Reduced 3.45%
16,800 $178,000
Q4 2023

Feb 14, 2024

SELL
$6.53 - $8.23 $28,732 - $36,212
-4,400 Reduced 20.18%
17,400 $140,000
Q3 2023

Nov 08, 2023

BUY
$7.69 - $9.71 $769 - $971
100 Added 0.46%
21,800 $181,000
Q2 2023

Jul 28, 2023

SELL
$5.72 - $8.8 $6,292 - $9,680
-1,100 Reduced 4.82%
21,700 $174,000
Q4 2022

Feb 07, 2023

BUY
$6.09 - $7.93 $138,852 - $180,804
22,800 New
22,800 $143,000
Q3 2021

Nov 04, 2021

SELL
$25.04 - $30.06 $25,014 - $30,029
-999 Closed
0 $0
Q1 2021

May 10, 2021

SELL
$21.37 - $34.38 $32,055 - $51,570
-1,500 Reduced 60.02%
999 $32,000
Q4 2020

Feb 16, 2021

BUY
$15.31 - $21.12 $24,480 - $33,770
1,599 Added 177.67%
2,499 $52,000
Q2 2020

Aug 10, 2020

SELL
$13.31 - $20.51 $199,876 - $307,998
-15,017 Reduced 94.35%
900 $16,000
Q1 2020

May 11, 2020

SELL
$12.98 - $30.25 $47,052 - $109,656
-3,625 Reduced 18.55%
15,917 $244,000
Q4 2019

Feb 13, 2020

SELL
$18.89 - $31.89 $128,452 - $216,852
-6,800 Reduced 25.81%
19,542 $586,000
Q3 2019

Nov 12, 2019

SELL
$20.88 - $25.66 $8,352 - $10,264
-400 Reduced 1.5%
26,342 $575,000
Q2 2019

Aug 12, 2019

SELL
$20.52 - $26.45 $23,167 - $29,862
-1,129 Reduced 4.05%
26,742 $676,000
Q4 2018

Feb 13, 2019

SELL
$17.64 - $28.32 $75,852 - $121,776
-4,300 Reduced 13.37%
27,871 $515,000
Q3 2018

Nov 13, 2018

BUY
$20.64 - $25.67 $664,009 - $825,829
32,171 New
32,171 $826,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.64B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Shell Asset Management CO Portfolio

Follow Shell Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.